NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
27 mars 2024 09h00 HE
|
NeurAxis, Inc.
CARMEL, Ind., March 27, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies...